Site Title

sbiomedic_the_micobiome_skin_expert

About

S-Biomedic brings novel therapeutic solutions in the skin microbiome.

The skin microbiome, a habitat of billions of good and bad bacteria, contributes to a healthy skin but a disbalance can lead to conditions ranging from acne, eczema, and rosacea to ageing.

S-Biomedic uses a technology of targeted modulation of the skin microbiome which can be applied in dermatology and the cosmetic industry.


We design our products using the latest advances in microbiology and dermatology. Using our technology, beneficial bacteria have been selected and combined to generate products that accelerate the rebalancing of a disease microbiome and restore a healthy state on your skin.

Our first target is acne vulgaris which is one of many skin diseases linked to the distortion of the microbiome.

Technology

More than 10.000 different bacteria strains colonise the human body. Next generation genomics technologies have revolutionized the research on the human microbiome in recent years.

It has become evident that the composition of the bacterial communities is tightly connected to the health of the human body (Belkaid and Segre, 2014; Consortium, 2012; Zhao, 2010). At the same time, distortions of the microbiome are connected to different diseases.

The targeted modulation of the human microbiome is revolutionizing therapy,
(Bakken et al, Clin. Gastro. and Hep. 2011).


We developed an advanced pipeline to select natural strains that influence the host-biome symbiosis, and microbiota population stability. We apply these complex formulations of natural skin bacteria to modulate the microbiome composition and regain skin homeostasis, which accelerates rebalancing from disease to healthy state.

Team


Veronika_Oudova

Veronika OudovaCEO

Veronika is a co-founder and Chief Executive Officer of S-Biomedic. On top of her education in management and entrepreneurship Veronika is inspired by scientific research and its social impact. Veronika has gained multiple years of experience in project and quality management, business development and planning in various industries including biotech and healthcare.


Berni_Paetzold

Berni PätzoldCSO

Bernhard has completed his PhD in synthetic biology, working together in collaboration with pharmaceutical industry on designing bacteria as a living pill. He is a scientific co-founder of S-Biomedic and is leading the research and product development. His passion is the complex interplay of the bacterial community living in and on us. He is fascinated by the unused potential of the active compounds naturally produced right on our skin everyday.


Berni_Paetzold

Marc GüellDirector

Marc is a scientific co-founder and non-executive director of S-Biomedic. He is a Wyss Technology Development Fellow at the Wyss Institute under the mentorship of mentor: George Church, Harvard Medical School. His research interests are centered in synthetic biology, and in biological technology development.


Berni_Paetzold

Carlos GallardoDirector

Carlos Gallardo has over 15 years of experience in the pharmaceutical industry in areas such as licensing, business development and country management. His expertise lies in negotiating strategic company and product acquisitions and investments.


Berni_Paetzold

Prof. Dr. Sven Quist

Prof. Dr. Dr. Sven Quist focuses on research in pharmacodynamics of inflammatory medication and drug metabolism, systemic and topical dermatotherapy and magistral formulations. Prof. Quist has experience in leading several pharmaceutical studies on different infectious skin diseases. Additionally he is qualified pharmacist and registered medical pharmacist.


Berni_Paetzold

Prof. Luis Serrano

Prof. Luis Serrano was previously active as head of the EMBL Structural & Computational Biology Program at the European Molecular Biology Institute in Heidelberg. Since 2011 he is the director of Center for Genomic Regulation (CRG). His group is a leader in Europe in the field of system and synthetic biology. He has authored more than 270 scientific publications and 20 patents.


Berni_Paetzold

Prof. Toni Gabaldon

As ICREA Research Professor Toni Gabaldon focuses on comparative genomics and phylogenomics to study the origin, evolution and function of complex biological systems. He has more than 290 scientific publications in the areas of genomics, microbiology and bioinformatics.


Berni_Paetzold

Bernat OlleBUSINESS

CEO of Vedanta and venture partner at PureTech

Contact

Let us know if you want to hear more…..

email: veronika.oudova@sbiomedic.com
phone:
+4915730066226

Stacks Image 12859

call: +49 1573 0066226
mail: contact@sbiomedic.com

Stacks Image 12865

call: +49 1573 0066226
mail: contact@sbiomedic.com

Clinical Research

Clinical Research

Imprint

S-Biomedic NV
Represented by managing director Veronika Oudova
Janssen Research Campus

address Turnhoutseweg 30, 2340 Beerse, Belgium
contact phone: +49 15730066226 email: contact@sbiomedic.com
Company and VAT number BE 0668.407.105

Imprint

S-Biomedic NV
Represented by managing director Veronika Oudova
Janssen Research Campus

address Turnhoutseweg 30, 2340 Beerse, Belgium
contact phone: +49 15730066226 email: contact@sbiomedic.com
Company and VAT number BE 0668.407.105